Page last updated: 2024-12-05

4,4'-bisphenol f

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4,4'-bisphenol F: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bisphenol F : A bisphenol that is methane in which two of the hydrogens have been replaced by 4-hydroxyphenyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12111
CHEMBL ID138061
CHEBI ID34575
SCHEMBL ID36454
MeSH IDM0052858

Synonyms (85)

Synonym
BIDD:ER0181
bis-(4-hydroxyphenyl)methane
phenol, 4,4'-methylenedi-
brn 2049425
4,4'-methylene diphenol
nsc 401136
4,4'-methylenebis(phenol)
einecs 210-658-2
4,4'-methylenebisphenol
inchi=1/c13h12o2/c14-12-5-1-10(2-6-12)9-11-3-7-13(15)8-4-11/h1-8,14-15h,9h
4,4'-methanediyl-di-phenol
620-92-8
4,4'-dihydroxydiphenylmethane
bis(4-hydroxyphenyl)methane
phenol, 4,4'-methylenebis-
4,4'-methylenediphenol
4,4'-methylenebis-phenol
4,4'-methylenebis[phenol]
nsc401136
p,p'-bis(hydroxyphenyl)methane
HDM ,
p-(p-hydroxybenzyl)phenol
nsc-401136
bisphenol f
bis(p-hydroxyphenyl)methane
phenol,4'-methylenebis-
wln: qr d1r dq
bis(4-hydroxyphenyl)methane, 98%
BPF ,
B0819
4-(4-hydroxybenzyl)phenol
CHEMBL138061
4,4-methylenediphenol
chebi:34575 ,
4,4'-bisphenol f
4,4-bisphenol f
ksc-19-052
KUC106448N ,
4-[(4-hydroxyphenyl)methyl]phenol
A833580
AE-562/40896944
NCGC00248941-01
tox21_201163
dtxsid9022445 ,
cas-620-92-8
NCGC00258715-01
dtxcid202445
qd2c19044z ,
ccris 9461
p,p'-bpf
unii-qd2c19044z
hsdb 8091
4-06-00-06664 (beilstein handbook reference)
pp-bip-f
FT-0617058
AKOS015909171
SCHEMBL36454
phenol, 4,4'-methylenebis
4,4'-bis-(hydroxyphenyl)methane
phenol, p,p'-methylenedi-
cid_12111
bdbm76093
bis-(p-hydroxyphenyl)methane
bis-(p-hydroxyphenyl)-methane
para-(para-hydroxybenzyl)phenol
bis(para-hydroxyphenyl)methane
W-109582
4,4-dihydroxydiphenylmethane
p,p'-methylenediphenol
4,4'-bis(hydroxyphenyl)methane
mfcd00002385
bisphenol??f, analytical standard
F16585
bp_04 (bpf)
4,4 inverted exclamation mark -methylenediphenol
SY048317
bisphenol f 100 microg/ml in acetonitrile
AS-17296
Q9658061
methyl2-methoxypropionate
bisphenol f 100 microg/ml in methanol
HY-W014901
T0U ,
CS-W015617
PD196956

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In this study, we observed behavioral adverse effects of the offspring of mice exposed to BPA or BPF in fetal period."( Adverse effects of maternal exposure to bisphenol F on the anxiety- and depression-like behavior of offspring.
Inoue, H; Iwano, H; Ohtani, N; Suda, K; Tanemura, K; Tsuji, E; Yokota, H, 2017
)
0.46
"Bisphenol A (BPA), a chemical incorporated into plastics and resins, has estrogenic activity and is associated with adverse health effects in humans and wildlife."( Acute Toxicity, Teratogenic, and Estrogenic Effects of Bisphenol A and Its Alternative Replacements Bisphenol S, Bisphenol F, and Bisphenol AF in Zebrafish Embryo-Larvae.
David, A; Kudoh, T; Lee, O; Moreman, J; Trznadel, M; Tyler, CR, 2017
)
0.46
" phospholipophilicity) were determined by immobilized artificial membrane liquid chromatography (IAM-LC) and possible relationships with in vitro toxic activity were also investigated."( Cytotoxicity of seven bisphenol analogues compared to bisphenol A and relationships with membrane affinity data.
Barbato, F; Capuozzo, A; Grumetto, L; Irace, C; Russo, G; Santamaria, R, 2018
)
0.48
" Since these analogues have been recently reported to show toxic properties similar to BPA, so they have attracted remarkable scientific attention."( Occurrence, toxicity and endocrine disrupting potential of Bisphenol-B and Bisphenol-F: A mini-review.
Ahmad, M; Ikhlas, S; Usman, A, 2019
)
0.51
" Since the replacement of BPA by its analogues, their presence has been found to increase in the environment leading to increased human exposure that makes it essential to investigate their toxic effects."( In vitro study to evaluate the cytotoxicity of BPA analogues based on their oxidative and genotoxic potential using human peripheral blood cells.
Ahmad, M; Ikhlas, S; Usman, A, 2019
)
0.51
" In this study, the toxic effects of polystyrene nanoplastics (PS-NPs) and BPF and their combined exposure on the submerged macrophytes Hydrilla verticillata (H."( Single and combined toxicity effects of nanoplastics and bisphenol F on submerged the macrophyte Hydrilla verticillata.
Huang, S; Luo, X; Yu, G; Zhao, W; Zheng, Z, 2022
)
0.72
" Therefore, the present study provides evidence that BPF, even at environmental concentrations, can be potentially adverse in terms of reproductive defects and offspring neurodevelopmental disorders."( Long-term exposure of zebrafish to bisphenol F: Adverse effects on parental reproduction and offspring neurodevelopment.
Fan, D; Gu, J; Guo, M; Ji, G; Li, L; Liang, M; Shi, L; Yin, X; Zhou, L; Zhu, Y, 2022
)
0.72
" Our results showed that many BPA analogues are more toxic than BPA in the embryonic zebrafish assay regarding teratogenic effect and mortality, which may partially due to differences in lipophilicity and/or different substitutes of structural function groups such as CF3, benzene, or cyclohexane."( Structure-based developmental toxicity and ASD-phenotypes of bisphenol A analogues in embryonic zebrafish.
Bai, C; Chen, J; Dong, Q; Huang, C; Lin, J; Song, Y; Tian, L; Zheng, Y, 2023
)
0.91
"Bisphenol F (BPF) and Bisphenol S (BPS) are safe alternatives substances? Here Drosophila melanogaster were exposed during development (larval stage) to BPF and BPS (0."( Safer alternatives? Bisphenol F and Bisphenol S induce oxidative stress in Drosophila melanogaster larvae and trigger developmental damage.
Fernandes, EJ; Guerra, GP; Janner, DE; Meichtry, LB; Mustafa Dahleh, MM; Poetini, MR; Prigol, M; Santos Musachio, EA, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" Research has shown that only the parent compounds have affinity to the estrogen receptors, suggesting that the pharmacokinetic behavior of bisphenols (BPs) can influence their potency."( Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.
Gramec Skledar, D; Hungerbühler, K; Karrer, C; Peterlin Mašič, L; Roiss, T; von Goetz, N, 2018
)
0.48
"Our goal was to compare the pharmacokinetic behaviors of BPA, BPS, BPF, and BPAF for different age groups after environmentally relevant external exposures by taking into account substance-specific metabolism kinetics and partitioning behavior."( Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.
Gramec Skledar, D; Hungerbühler, K; Karrer, C; Peterlin Mašič, L; Roiss, T; von Goetz, N, 2018
)
0.48
"We readjusted a physiologically based pharmacokinetic (PBPK) model for peroral exposure to BPA and extended it to include dermal exposure."( Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.
Gramec Skledar, D; Hungerbühler, K; Karrer, C; Peterlin Mašič, L; Roiss, T; von Goetz, N, 2018
)
0.48
" The pharmacokinetic profile was also obtained."( Pharmacokinetics and toxicity evaluation following oral exposure to bisphenol F.
An, KS; Chae, C; Kim, HJ; Lee, J; Lee, S; Noh, HJ; Ryu, HY; Song, KS, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
"The bioconcentration factor (BCF) is a key parameter for bioavailability assessment of environmental pollutants in regulatory frameworks."( Predicting bioconcentration factor and estrogen receptor bioactivity of bisphenol a and its analogues in adult zebrafish by directed message passing neural networks.
Chen, G; Chen, P; He, K; Shan, G; Wang, R; Yang, L; Zhu, L, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
" In pregnant rats dosed at day 17 of gestation, BPF residues were detected in the uterus, placenta, amniotic fluid, and fetuses (0."( Disposition and metabolic profiling of bisphenol F in pregnant and nonpregnant rats.
Cabaton, N; Chagnon, MC; Cravedi, JP; Lhuguenot, JC; Zalko, D, 2006
)
0.33
"05) in response to each dosage of bisphenol analogs exposures."( Effects of bisphenol A and its analogs bisphenol F and S on life parameters, antioxidant system, and response of defensome in the marine rotifer Brachionus koreanus.
Han, J; Hwang, UK; Jung, JH; Kim, M; Lee, JS; Lee, MC; Park, JC; Yoon, DS, 2018
)
0.48
" The dose-response relationship was explored by the restricted cubic spline model."( Association of bisphenol A and its alternatives bisphenol S and F exposure with hypertension and blood pressure: A cross-sectional study in China.
Jiang, S; Liu, H; Lu, Q; Peng, C; Tong, Y; Zhang, X; Zhou, H; Zhou, S, 2020
)
0.56
" hASCs with BPF or BPS produced a linear dose-response increase in intracellular lipid accumulation and in gene expression of the adipogenic markers, confirmed by protein levels."( Bisphenol F and bisphenol S promote lipid accumulation and adipogenesis in human adipose-derived stem cells.
Fernández, MF; Molina-Molina, JM; Mustieles, V; Olea, N; Olivas-Martínez, A; Reina-Pérez, I; Ruiz-Ojeda, FJ, 2021
)
0.62
" The Bayesian kernel machine regression (BKMR) and restricted cubic spline (RCS) models showed a U-shaped dose-response relationship between bisphenol A (BPA) and free triiodothyronine (FT3) (p < 0."( Associations of bisphenol exposure with thyroid hormones in pregnant women: a prospective birth cohort study in China.
Fan, H; Huang, D; Huang, H; Liang, J; Liao, Q; Liu, S; Long, J; Pan, D; Qiu, X; Tang, P; Yu, C; Zeng, X, 2022
)
0.72
" Our results demonstrate that sustained BPF exposure at an environmentally relevant dosage may substantially improve glucose metabolism and enhance insulin sensitivity in mice fed a high-fat diet."( In vivo hypoglycemic effects of bisphenol F exposure in high-fat diet mice.
Cao, T; Chen, Y; Guo, Y; Hou, C; Hu, X; Huang, S; Ke, Y; Liu, G; Lv, Z; Peng, C; Tang, Z; Wei, X; Zeng, H; Zou, X, 2023
)
0.91
" Moreover, we observed significant dose-response relationships between TT4 and the mixture of 11 EDCs, and BPF was the main contributor to the mixture effect, suggesting the priority of potential effect of BPF on disrupting thyroid function under a real scenario of human exposure to multiple EDCs."( Human exposure to a mixture of endocrine disruptors and serum levels of thyroid hormones: A cross-sectional study.
Bao, Y; Fan, S; Fang, C; Li, J; Miao, H; Ning, S; Wu, Y; Yue, B; Zhang, L; Zhao, Y, 2023
)
0.91
" Both BPA and BPS showed a positive dose-response relationship with trunk fat (BPA: P=."( Association Between Urinary Bisphenols and Body Composition Among American Adults: Cross-Sectional National Health and Nutrition Examination Survey Study.
Deng, Q; Dong, Q; Li, J; Li, Y; Qiu, S; Shen, B; Tang, T; Wang, J; Wei, Q; Wu, E; Wu, R; Yang, L; Zhang, C; Zhang, Y; Zhang, Z; Zhao, J; Zheng, J; Zhu, Q; Zong, H, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
environmental food contaminantAny unwanted chemical in food. The term includes agrochemicals and industrial chemicals that may contaminate foodstuffs during their production, transportation or storage.
xenoestrogenA synthetic or semi-synthetic compound that has oestrogenic activity.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
diarylmethaneAny compound containing two aryl groups connected by a single C atom.
bisphenolBy usage, the methylenediphenols, HOC6H4CH2C6H4OH, commonly p,p-methylenediphenol, and their substitution products (generally derived from condensation of two equivalent amounts of a phenol with an aldehyde or ketone). The term also includes analogues in the the methylene (or substituted methylene) group has been replaced by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (21)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency40.24080.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency27.24910.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency41.22730.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency22.05040.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743036; AID743053; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency10.38130.000657.913322,387.1992AID1259377; AID1259378; AID1259394
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency46.17840.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency30.88730.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency27.13150.003041.611522,387.1992AID1159552; AID1159553; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency54.92620.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.50880.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743075; AID743077; AID743079
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency19.65130.001019.414170.9645AID743191
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency24.53460.001723.839378.1014AID743083
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency24.53460.000323.4451159.6830AID743066
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency26.75830.000627.21521,122.0200AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency12.29640.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency12.29640.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Estrogen receptorHomo sapiens (human)IC50 (µMol)5.71350.00000.723732.7000AID1594506; AID1594508
large T antigenBetapolyomavirus macacaeIC50 (µMol)70.10000.160024.9724100.0000AID485288
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Estrogen receptorHomo sapiens (human)EC50 (µMol)3.93970.00000.53054.4000AID1594507; AID1594509; AID758904
Melatonin receptor type 1AHomo sapiens (human)EC50 (µMol)237.00000.00000.01530.2570AID1591601
Melatonin receptor type 1BHomo sapiens (human)EC50 (µMol)244.00000.00010.34027.0000AID1591602
Estrogen receptor betaHomo sapiens (human)EC50 (µMol)1.90000.00000.47954.8900AID758901
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (62)

Processvia Protein(s)Taxonomy
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
antral ovarian follicle growthEstrogen receptorHomo sapiens (human)
epithelial cell developmentEstrogen receptorHomo sapiens (human)
chromatin remodelingEstrogen receptorHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
signal transductionEstrogen receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayEstrogen receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationEstrogen receptorHomo sapiens (human)
androgen metabolic processEstrogen receptorHomo sapiens (human)
male gonad developmentEstrogen receptorHomo sapiens (human)
negative regulation of gene expressionEstrogen receptorHomo sapiens (human)
positive regulation of phospholipase C activityEstrogen receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayEstrogen receptorHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptorHomo sapiens (human)
response to estradiolEstrogen receptorHomo sapiens (human)
regulation of toll-like receptor signaling pathwayEstrogen receptorHomo sapiens (human)
negative regulation of smooth muscle cell apoptotic processEstrogen receptorHomo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionEstrogen receptorHomo sapiens (human)
negative regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
response to estrogenEstrogen receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
fibroblast proliferationEstrogen receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEstrogen receptorHomo sapiens (human)
stem cell differentiationEstrogen receptorHomo sapiens (human)
regulation of inflammatory responseEstrogen receptorHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
RNA polymerase II preinitiation complex assemblyEstrogen receptorHomo sapiens (human)
uterus developmentEstrogen receptorHomo sapiens (human)
vagina developmentEstrogen receptorHomo sapiens (human)
prostate epithelial cord elongationEstrogen receptorHomo sapiens (human)
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesisEstrogen receptorHomo sapiens (human)
regulation of branching involved in prostate gland morphogenesisEstrogen receptorHomo sapiens (human)
mammary gland branching involved in pregnancyEstrogen receptorHomo sapiens (human)
mammary gland alveolus developmentEstrogen receptorHomo sapiens (human)
epithelial cell proliferation involved in mammary gland duct elongationEstrogen receptorHomo sapiens (human)
protein localization to chromatinEstrogen receptorHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptorHomo sapiens (human)
negative regulation of miRNA transcriptionEstrogen receptorHomo sapiens (human)
regulation of epithelial cell apoptotic processEstrogen receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptorHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMelatonin receptor type 1AHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayMelatonin receptor type 1AHomo sapiens (human)
mating behaviorMelatonin receptor type 1AHomo sapiens (human)
circadian rhythmMelatonin receptor type 1AHomo sapiens (human)
G protein-coupled receptor signaling pathwayMelatonin receptor type 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMelatonin receptor type 1BHomo sapiens (human)
chemical synaptic transmissionMelatonin receptor type 1BHomo sapiens (human)
negative regulation of cGMP-mediated signalingMelatonin receptor type 1BHomo sapiens (human)
glucose homeostasisMelatonin receptor type 1BHomo sapiens (human)
camera-type eye developmentMelatonin receptor type 1BHomo sapiens (human)
negative regulation of neuron apoptotic processMelatonin receptor type 1BHomo sapiens (human)
negative regulation of vasoconstrictionMelatonin receptor type 1BHomo sapiens (human)
positive regulation of circadian sleep/wake cycle, non-REM sleepMelatonin receptor type 1BHomo sapiens (human)
negative regulation of insulin secretionMelatonin receptor type 1BHomo sapiens (human)
regulation of insulin secretionMelatonin receptor type 1BHomo sapiens (human)
negative regulation of cytosolic calcium ion concentrationMelatonin receptor type 1BHomo sapiens (human)
negative regulation of transmission of nerve impulseMelatonin receptor type 1BHomo sapiens (human)
positive regulation of transmission of nerve impulseMelatonin receptor type 1BHomo sapiens (human)
regulation of neuronal action potentialMelatonin receptor type 1BHomo sapiens (human)
G protein-coupled receptor signaling pathwayMelatonin receptor type 1BHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
signal transductionEstrogen receptor betaHomo sapiens (human)
cell-cell signalingEstrogen receptor betaHomo sapiens (human)
negative regulation of cell growthEstrogen receptor betaHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptor betaHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptor betaHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (33)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
TFIIB-class transcription factor bindingEstrogen receptorHomo sapiens (human)
transcription coregulator bindingEstrogen receptorHomo sapiens (human)
transcription corepressor bindingEstrogen receptorHomo sapiens (human)
transcription coactivator bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
chromatin bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
nuclear receptor activityEstrogen receptorHomo sapiens (human)
steroid bindingEstrogen receptorHomo sapiens (human)
protein bindingEstrogen receptorHomo sapiens (human)
calmodulin bindingEstrogen receptorHomo sapiens (human)
beta-catenin bindingEstrogen receptorHomo sapiens (human)
zinc ion bindingEstrogen receptorHomo sapiens (human)
TBP-class protein bindingEstrogen receptorHomo sapiens (human)
enzyme bindingEstrogen receptorHomo sapiens (human)
protein kinase bindingEstrogen receptorHomo sapiens (human)
nitric-oxide synthase regulator activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor bindingEstrogen receptorHomo sapiens (human)
estrogen response element bindingEstrogen receptorHomo sapiens (human)
identical protein bindingEstrogen receptorHomo sapiens (human)
ATPase bindingEstrogen receptorHomo sapiens (human)
14-3-3 protein bindingEstrogen receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingEstrogen receptorHomo sapiens (human)
protein bindingMelatonin receptor type 1AHomo sapiens (human)
melatonin receptor activityMelatonin receptor type 1AHomo sapiens (human)
hormone bindingMelatonin receptor type 1AHomo sapiens (human)
organic cyclic compound bindingMelatonin receptor type 1AHomo sapiens (human)
G protein-coupled receptor activityMelatonin receptor type 1AHomo sapiens (human)
protein bindingMelatonin receptor type 1BHomo sapiens (human)
melatonin receptor activityMelatonin receptor type 1BHomo sapiens (human)
G protein-coupled receptor activityMelatonin receptor type 1BHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptor betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptor betaHomo sapiens (human)
DNA bindingEstrogen receptor betaHomo sapiens (human)
nuclear steroid receptor activityEstrogen receptor betaHomo sapiens (human)
nuclear receptor activityEstrogen receptor betaHomo sapiens (human)
steroid bindingEstrogen receptor betaHomo sapiens (human)
protein bindingEstrogen receptor betaHomo sapiens (human)
zinc ion bindingEstrogen receptor betaHomo sapiens (human)
enzyme bindingEstrogen receptor betaHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptor betaHomo sapiens (human)
estrogen response element bindingEstrogen receptor betaHomo sapiens (human)
receptor antagonist activityEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
nucleusEstrogen receptorHomo sapiens (human)
nucleoplasmEstrogen receptorHomo sapiens (human)
transcription regulator complexEstrogen receptorHomo sapiens (human)
cytoplasmEstrogen receptorHomo sapiens (human)
Golgi apparatusEstrogen receptorHomo sapiens (human)
cytosolEstrogen receptorHomo sapiens (human)
plasma membraneEstrogen receptorHomo sapiens (human)
membraneEstrogen receptorHomo sapiens (human)
chromatinEstrogen receptorHomo sapiens (human)
euchromatinEstrogen receptorHomo sapiens (human)
protein-containing complexEstrogen receptorHomo sapiens (human)
nucleusEstrogen receptorHomo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
plasma membraneMelatonin receptor type 1AHomo sapiens (human)
receptor complexMelatonin receptor type 1AHomo sapiens (human)
plasma membraneMelatonin receptor type 1AHomo sapiens (human)
plasma membraneMelatonin receptor type 1BHomo sapiens (human)
synapseMelatonin receptor type 1BHomo sapiens (human)
plasma membraneMelatonin receptor type 1BHomo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
nucleoplasmEstrogen receptor betaHomo sapiens (human)
mitochondrionEstrogen receptor betaHomo sapiens (human)
intracellular membrane-bounded organelleEstrogen receptor betaHomo sapiens (human)
chromatinEstrogen receptor betaHomo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID1594510Selective estrogen receptor down-regulator activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ERalpha degradation by luciferase reporter gene assay relative to untreated control2019Bioorganic & medicinal chemistry, 05-15, Volume: 27, Issue:10
Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton.
AID1124828Antagonist activity at human Gal4-fused ER-beta expressed in HEK293 cells assessed as inhibition of 17beta-estradiol-induced effect by luciferase reporter gene assay2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character.
AID1594507Agonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ER-alpha-mediated transcriptional activity by luciferase reporter gene assay2019Bioorganic & medicinal chemistry, 05-15, Volume: 27, Issue:10
Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton.
AID1594509Selective estrogen receptor down-regulator activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ERalpha degradation by luciferase reporter gene assay2019Bioorganic & medicinal chemistry, 05-15, Volume: 27, Issue:10
Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton.
AID475504Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1869400Antifungal activity against Penicillium chrysogenum IBWF assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869399Antifungal activity against Rhizomucor miehei assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1594508Antagonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as reduction in E2-induced ER-alpha-mediated transcriptional activity by luciferase reporter gene assay2019Bioorganic & medicinal chemistry, 05-15, Volume: 27, Issue:10
Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton.
AID1591601Agonist activity at MT1 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay2019Bioorganic & medicinal chemistry, 08-01, Volume: 27, Issue:15
Polybenzyls from Gastrodia elata, their agonistic effects on melatonin receptors and structure-activity relationships.
AID1869397Antibacterial activity against Staphylococcus aureus ATCC 11632 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1591600Agonist activity at MT2 receptor (unknown origin) expressed in HEK293 cells at 0.5 mM by Fluo-8 dye-based calcium assay relative to control2019Bioorganic & medicinal chemistry, 08-01, Volume: 27, Issue:15
Polybenzyls from Gastrodia elata, their agonistic effects on melatonin receptors and structure-activity relationships.
AID46670Fraction of total radioactivity [86Rb] remaining with the compound at a concentration of 10 uM in COS-7 cells1998Journal of medicinal chemistry, Oct-22, Volume: 41, Issue:22
Bisphenols that stimulate cells to release alkali metal cations: a structure-activity study.
AID475505Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1869402Antifungal activity against Phytophthora infestans CBS 430.90 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1591602Agonist activity at MT2 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay2019Bioorganic & medicinal chemistry, 08-01, Volume: 27, Issue:15
Polybenzyls from Gastrodia elata, their agonistic effects on melatonin receptors and structure-activity relationships.
AID1869396Antibacterial activity against Aneurinibacillus migulanus ATCC 9999 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1591599Agonist activity at MT1 receptor (unknown origin) expressed in HEK293 cells at 0.5 mM by Fluo-8 dye-based calcium assay relative to control2019Bioorganic & medicinal chemistry, 08-01, Volume: 27, Issue:15
Polybenzyls from Gastrodia elata, their agonistic effects on melatonin receptors and structure-activity relationships.
AID1869401Antifungal activity against Paecilomyces variotii ETH 114646 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1124823Antagonist activity at human Gal4-fused ER-alpha expressed in HEK293 cells assessed as inhibition of 17beta-estradiol-induced effect at 3 uM by luciferase reporter gene assay2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character.
AID736009Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader2013Journal of natural products, Feb-22, Volume: 76, Issue:2
Flavone tetraglycosides and benzyl alcohol glycosides from the Mongolian medicinal plant Dracocephalum ruyschiana.
AID758900Antagonist activity at human Gal4-ERalpha assessed as inhibition of 17beta-estradiol-induced effect at 3 uM by reporter gene assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
AID1869403Antifungal activity against Candida albicans ATCC 90028 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869395Cytotoxicity against human HeLa S3 cells assessed as cell viability incubated for 48 hrs by microscopic analysis
AID1594506Binding affinity to GST-tagged human ER alpha ligand-binding domain by TR-FRET assay2019Bioorganic & medicinal chemistry, 05-15, Volume: 27, Issue:10
Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton.
AID758901Agonist activity at human Gal4-ERbeta by reporter gene assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
AID752867Inhibition of rabbit skeletal muscle sarco/endoplasmic reticulum calcium ATPase assessed as inhibition of ATP hydrolysis by spectrophotometric analysis2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Structural requirements for inhibitory effects of bisphenols on the activity of the sarco/endoplasmic reticulum calcium ATPase.
AID758904Agonist activity at human Gal4-ERalpha by reporter gene assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
AID1869398Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID758897Antagonist activity at human Gal4-ERbeta assessed as inhibition of 17beta-estradiol-induced effect at 3 uM by reporter gene assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (295)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (1.02)18.7374
1990's2 (0.68)18.2507
2000's8 (2.71)29.6817
2010's114 (38.64)24.3611
2020's168 (56.95)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.59 (24.57)
Research Supply Index5.69 (2.92)
Research Growth Index6.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews13 (4.41%)6.00%
Case Studies2 (0.68%)4.05%
Observational0 (0.00%)0.25%
Other280 (94.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]